Drugs with anticholinergic properties: cognitive and neuropsychiatric side-effects in elderly patients.
about
Impact of pain on cognitive functions in primary Sjögren syndrome with small fiber neuropathy: 10 cases and a literature review.Pharmacist participation in hospital ward teams and hospital readmission rates among people with dementia: a randomized controlled trial.Drug Burden Index in older adults: theoretical and practical issues.Proton Magnetic Resonance Spectroscopy in adult cancer patients with delirium.Effects of discontinuing anticholinergic treatment on movement disorders, cognition and psychopathology in patients with schizophreniaPsychotropic drug use among people with dementia--a six-month follow-up study.Medication management for people with dementia in primary care: description of implementation in the DelpHi study.A clinical update on delirium: from early recognition to effective management.Do drug treatment variables predict cognitive performance in multidrug-treated opioid-dependent patients? A regression analysis study.Preclinical profile of ITI-214, an inhibitor of phosphodiesterase 1, for enhancement of memory performance in rats.Drugs with anticholinergic properties: a potential risk factor for psychosis onset in Alzheimer's disease?Anticholinergics in the era of atypical antipsychotics: short-term or long-term treatment?Anticholinergic drug burden in older people's brain - how well is it measured?Enabling a multidisciplinary approach to the study of ageing and Alzheimer's disease: an update from the Australian Imaging Biomarkers and Lifestyle (AIBL) study.Reduction in the use of potentially inappropriate drugs among old people living in geriatric care units between 2007 and 2013.Bladder antimuscarinics and cognitive decline in elderly patients.Anticholinergic drugs and negative outcomes in the older population: from biological plausibility to clinical evidence.Anticholinergics: theoretical and clinical overview.Anticholinergic drugs and functional, cognitive impairment and behavioral disturbances in patients from a memory clinic with subjective cognitive decline or neurocognitive disorders.Capturing side-effect of medication to identify persons at risk of delirium.Pharmacist-initiated management of antagonistic interactions between anticholinergic drugs and acetyl cholinesterase inhibitors in individuals with dementia.Relationship between anticholinergic drug use and one-year outcome among elderly people hospitalised in medical wards via emergency department: the SAFES cohort study.Anticholinergic Exposure in a Cohort of Adults Aged 80 years and Over: Associations of the MARANTE Scale with Mortality and Hospitalization.Multiple anticholinergic medication use and risk of hospital admission for confusion or dementia.Cognitive side-effects of electroconvulsive therapy in elderly depressed patients.Total anticholinergic burden and survival within a cohort of elderly Mexican Americans.Development of the PHASE-Proxy scale for rating drug-related signs and symptoms in severe cognitive impairment.Low preoperative plasma cholinesterase activity as a risk marker of postoperative delirium in elderly patients.Health Service Use, Costs, and Adverse Events Associated with Potentially Inappropriate Medication in Old Age in Germany: Retrospective Matched Cohort Study.Links Between Chronic Illness and Late-Life Cognition: Evidence From Four Latin American Countries.Anticholinergic Burden and Most Common Anticholinergic-acting Medicines in Older General Practice Patients.
P2860
Q33606052-5A57BACE-58F1-44DA-B142-D1151BF9A8BFQ33841837-F6DFBDFD-9840-4885-A8E7-EABCE123B235Q34198674-57D2302B-5E13-44A1-A8E8-100C8A015C7FQ34538255-E80E459C-C419-43DD-9723-D241D73174ABQ34642857-C81D94C8-C97D-4BDF-A5AD-C2467C65F04AQ35033086-C9C53C7E-6D43-4B41-B356-6E73F99F1DD8Q35041890-8C09DECD-2C66-421F-A6A6-9DF0C5145499Q35203207-D3B29F24-D201-4E8A-881F-D88DEC9098B8Q36552459-07A6B4D3-9D44-476A-8A79-A7FAD1FA9521Q37166063-5AD494A4-5C97-4853-ADE4-B20B1D04575CQ37529854-3107B4B7-0BD3-44FA-A903-D6B6DEAA1653Q38014996-F3903770-CCB9-4E21-8C03-09B83C466A26Q38151217-F0F1F01B-068D-414B-9647-808899C4C385Q38178373-9C7F42C5-5A00-40A6-B480-2B3B30762837Q38365347-0CA191F2-0B6E-4994-BCE1-1DA512AFF674Q38377308-0E7E798F-7BAB-424F-B21E-1759EAD0F15EQ38452282-04804F18-26AA-4C82-8DA4-7A1F3C3F2FDBQ38769800-36833C8D-F0CE-4C63-A259-0024F8798BDDQ41214474-F4A279FF-00C8-43D1-B978-C2937E3EB6F0Q42745476-C2B731AA-E469-439C-95F1-819FFDF378FDQ43846463-F5909E64-99DA-4A17-BC4D-DCF5B4E004C4Q44541539-A42F8C16-32B7-4332-B831-4AE24E00A950Q47913293-E5342D12-B4EF-4139-8C93-6C5E6B2A1391Q48198202-C3BA3B49-4607-457B-8298-2E4D4775E7FDQ48213553-61F40A22-F679-4F42-B81E-0A580D688136Q48308661-077FC760-03D0-46E9-B78B-B7B8C62B0899Q48339977-76FE7CFD-BDB6-4444-A3E4-AA3CEA96C1DAQ50802221-6740A9BC-0B9E-4AC9-96FC-B012412E7012Q51332063-397129FA-B779-4C1A-9DF1-F824E19C1E7CQ53780040-F7F5D98E-40FE-46CD-8400-E86DBB4A2C48Q55432805-6D0D18D2-A2A9-401E-B4EB-3829B5B690EB
P2860
Drugs with anticholinergic properties: cognitive and neuropsychiatric side-effects in elderly patients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Drugs with anticholinergic pro ...... e-effects in elderly patients.
@en
Drugs with anticholinergic pro ...... e-effects in elderly patients.
@nl
type
label
Drugs with anticholinergic pro ...... e-effects in elderly patients.
@en
Drugs with anticholinergic pro ...... e-effects in elderly patients.
@nl
prefLabel
Drugs with anticholinergic pro ...... e-effects in elderly patients.
@en
Drugs with anticholinergic pro ...... e-effects in elderly patients.
@nl
P2093
P2860
P1476
Drugs with anticholinergic pro ...... e-effects in elderly patients.
@en
P2093
Gian Luigi Gigli
Iacopo Cancelli
Massimiliano Beltrame
P2860
P2888
P356
10.1007/S10072-009-0033-Y
P577
2009-02-20T00:00:00Z